Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A18528 | 27068982 | Biochem Soc Trans | Blood triacylglycerols: a lipidomic window on diet and disease. | 2016 | Details |
| A18538 | 27063275 | Clin Liver Dis | Emerging Therapies for Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18539 | 27063274 | Clin Liver Dis | Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18546 | 27063267 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease: Lipids and Insulin Resistance. | 2016 | Details |
| A18547 | 27063266 | Clin Liver Dis | The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis. | 2015 | Details |
| A18554 | 28702244 | Clin Diabetes Endocrinol | Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus. | 2016 | Details |
| A18560 | 27057272 | Oxid Med Cell Longev | Aging Increases Susceptibility to High Fat Diet-Induced Metabolic Syndrome in C57BL/6 Mice: Improvement in Glycemic and Lipid Profile after Antioxidant Therapy. | 2016 | Details |
| A18577 | 27051590 | BBA Clin | Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obese. | 2016 | Details |
| A18578 | 27049488 | Ann Hepatol | Nonalcoholic steatohepatitis in morbid obese patients: coffee consumption vs. disease severity. | 2017 | Details |
| A18579 | 27049380 | Int J Mol Sci | Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant. | 2016 | Details |
| A18585 | 27045862 | Sci Rep | Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies. | 2016 | Details |
| A18591 | 27043550 | Int J Mol Sci | Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. | 2016 | Details |
| A18592 | 27043543 | Int J Mol Sci | Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load. | 2016 | Details |
| A18596 | 27041377 | Dig Dis Sci | Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children. | 2016 | Details |
| A18601 | 27040340 | Yakugaku Zasshi | [An Overview of NAFLD/NASH in Japan]. | 2016 | Details |
| A18605 | 27038448 | Dig Dis Sci | Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations. | 2016 | Details |
| A18614 | 27032902 | J Appl Physiol (1985) | Short-term aerobic exercise training improves gut peptide regulation in nonalcoholic fatty liver disease. | 2016 | Details |
| A18615 | 27032381 | J Hepatol | Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis. | 2016 | Details |
| A18622 | 30234279 | Trop Gastroenterol | Elevated levels of serum uric acid and insulin resistance are associated with nonalcoholic fatty liver disease among prediabetic subjects. | 2018 | Details |
| A18631 | 27023537 | Int J Mol Sci | Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients. | 2016 | Details |
| A18637 | 27020118 | Clin Chim Acta | Relationship between non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance in Korean adults: A cross-sectional study. | 2016 | Details |
| A18638 | 27019761 | Scientifica (Cairo) | A High-Fat, High-Fructose Diet Induces Antioxidant Imbalance and Increases the Risk and Progression of Nonalcoholic Fatty Liver Disease in Mice. | 2016 | Details |
| A18640 | 27019188 | J Cell Mol Med | MicroRNA-20a-5p contributes to hepatic glycogen synthesis through targeting p63 to regulate p53 and PTEN expression. | 2016 | Details |
| A18641 | 27019073 | Eur J Clin Invest | Sfrp5 associates with beta-cell function in humans. | 2016 | Details |
| A18645 | 27017224 | Dig Dis Sci | Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016. | 2016 | Details |
| A18648 | 27016281 | J Hepatol | DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity. | 2016 | Details |
| A18654 | 27012627 | J Nutr Biochem | Hydroxytyrosol prevents metabolic impairment reducing hepatic inflammation and restoring duodenal integrity in a rat model of NAFLD. | 2016 | Details |
| A18663 | 27005704 | Sci Rep | Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC. | 2016 | Details |
| A18664 | 27005620 | Int J Mol Sci | Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight. | 2016 | Details |
| A18667 | 27004021 | Clujul Med | Current Management of NAFLD. | 2016 | Details |
| A18675 | 27002796 | Am J Gastroenterol | Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18683 | 26999104 | Int J Mol Sci | Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics. | 2016 | Details |
| A18690 | 26997538 | Metabolism | Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. | 2016 | Details |
| A18695 | 26997000 | Clin Cardiol | Fatty Liver, Insulin Resistance, and Obesity: Relationships With Increase in Coronary Artery Calcium Over Time. | 2016 | Details |
| A18697 | 26994931 | Endocrine | Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK. | 2016 | Details |
| A18699 | 26993825 | Dig Dis Sci | Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2016 | Details |
| A18707 | 26989059 | Obes Surg | Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency. | 2016 | Details |
| A18711 | 26985230 | Iran J Nurs Midwifery Res | The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A18723 | 26983396 | Int J Food Sci Nutr | Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study. | 2016 | Details |
| A18729 | 26980291 | J Invest Surg | Fetuin A is a Predictor of Liver Fat in Preoperative Patients with Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18730 | 26980160 | Annu Rev Pathol | Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum. | 2016 | Details |
| A18734 | 26978730 | Child Obes | Sleep Duration and Media Time Have a Major Impact on Insulin Resistance and Metabolic Risk Factors in Obese Children and Adolescents. | 2016 | Details |
| A18735 | 26978356 | Int J Mol Sci | Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome. | 2016 | Details |
| A18736 | 26977813 | PLoS One | Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction. | 2016 | Details |
| A18738 | 26977755 | Am J Gastroenterol | Non-Alcoholic Fatty Liver Disease in Early Pregnancy Predicts Dysglycemia in Mid-Pregnancy: Prospective Study. | 2016 | Details |
| A18739 | 26977393 | Mol Metab | Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption. | 2016 | Details |
| A18743 | 26976243 | Am J Pathol | Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance. | 2016 | Details |
| A18744 | 26975539 | Metabolism | Plasma osteoprotegerin levels are inversely associated with nonalcoholic fatty liver disease in patients with type 2 diabetes: A case-control study in China. | 2015 | Details |
| A18746 | 26973390 | World J Gastroenterol | Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression. | 2016 | Details |
| A18749 | 26972165 | Best Pract Res Clin Obstet Gynaecol | Metabolic syndrome, diet and exercise. | 2016 | Details |
| A18751 | 26971826 | Gastroenterology | Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management. | 2016 | Details |
| A18752 | 26971824 | Gastroenterology | Perspectives on Treatment for Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18759 | 26965771 | Asia Pac J Clin Nutr | Insulin resistance, body composition, and fat distribution in obese children with nonalcoholic fatty liver disease. | 2016 | Details |
| A18760 | 26965314 | Lipids Health Dis | Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review. | 2016 | Details |
| A18762 | 26962021 | Biochim Biophys Acta | Nuclear receptors and nonalcoholic fatty liver disease. | 2016 | Details |
| A18766 | 26959535 | J Pediatr Endocrinol Metab | Serum vascular endothelial cadherin and thrombomodulin are markers of non-alcoholic fatty liver disease in children. | 2016 | Details |
| A18767 | 26959059 | Nutrients | The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus. | 2016 | Details |
| A18768 | 26957957 | Afr Health Sci | Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis. | 2015 | Details |
| A18773 | 26952573 | Exp Gerontol | β2-Adrenergic receptor ablation modulates hepatic lipid accumulation and glucose tolerance in aging mice. | 2016 | Details |
| A18776 | 26949499 | Iran J Basic Med Sci | Interactions of smoking with rs833061 polymorphism on the risk of non-alcoholic fat liver disease in Hubei Han population: a preliminary case-control study. | 2015 | Details |
| A18779 | 26947067 | Cell Rep | The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. | 2016 | Details |
| A18788 | 26941037 | J Endocrinol | Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis. | 2016 | Details |
| A18810 | 26926384 | Hepatology | Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice. | 2016 | Details |
| A18817 | 26923892 | Arch Iran Med | Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice. | 2016 | Details |
| A18821 | 26921205 | Adv Ther | The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans. | 2016 | Details |
| A18824 | 26919573 | Hepatology | A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. | 2016 | Details |
| A18830 | 26914024 | PLoS One | White Pitaya (Hylocereus undatus) Juice Attenuates Insulin Resistance and Hepatic Steatosis in Diet-Induced Obese Mice. | 2016 | Details |
| A18838 | 26909311 | Mol Metab | Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity. | 2015 | Details |
| A18839 | 26909307 | Mol Metab | High intensity interval training improves liver and adipose tissue insulin sensitivity. | 2015 | Details |
| A18840 | 26909306 | Mol Metab | Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism. | 2015 | Details |
| A18843 | 26907206 | Metabolism | Nonalcoholic fatty liver disease and hepatocellular carcinoma. | 2016 | Details |
| A18846 | 26905606 | J Clin Gastroenterol | Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006. | 2016 | Details |
| A18855 | 26900270 | J Clin Exp Hepatol | Risk Factors Associated With Non-Alcoholic Fatty Liver Disease in Indians: A Case-Control Study. | 2015 | Details |
| A18865 | 26894897 | Cell Mol Life Sci | Pathogenesis of nonalcoholic steatohepatitis. | 2016 | Details |
| A18871 | 26892520 | Metabolism | Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study. | 2015 | Details |
| A18873 | 26891869 | Biochem Biophys Res Commun | The molecular mechanisms between metabolic syndrome and breast cancer. | 2016 | Details |
| A18875 | 26890135 | Cell Death Dis | Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease. | 2016 | Details |
| A18882 | 26888280 | Br J Nutr | Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)). | 2016 | Details |
| A18890 | 26882989 | Nat Commun | Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling. | 2016 | Details |
| A18895 | 26881239 | J Diabetes Res | Vitamin B6 Prevents Endothelial Dysfunction, Insulin Resistance, and Hepatic Lipid Accumulation in Apoe (-/-) Mice Fed with High-Fat Diet. | 2015 | Details |
| A18898 | 26880786 | J Lipid Res | Mogat1 deletion does not ameliorate hepatic steatosis in lipodystrophic (Agpat2-/-) or obese (ob/ob) mice. | 2016 | Details |
| A18903 | 26878184 | Pediatr Ann | Nonalcoholic Fatty Liver Disease in Pediatrics. | 2016 | Details |
| A18910 | 26873633 | Biochim Biophys Acta | iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling. | 2016 | Details |
| A18915 | 26871756 | Can J Physiol Pharmacol | The ergogenic supplement β-hydroxy-β-methylbutyrate (HMB) attenuates insulin resistance through suppressing GLUT-2 in rat liver. | 2015 | Details |
| A18917 | 26871288 | Oncotarget | Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice. | 2016 | Details |
| A18929 | 26866272 | Cell Death Dis | Loss of Fas apoptosis inhibitory molecule leads to spontaneous obesity and hepatosteatosis. | 2016 | Details |
| A18932 | 26861926 | Diabetes Care | Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes. | 2016 | Details |
| A18933 | 26861390 | Nutrients | Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice. | 2016 | Details |
| A18936 | 26860405 | J Hepatol | Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis. | 2016 | Details |
| A18940 | 26858440 | Proc Natl Acad Sci U S A | Effective treatment of steatosis and steatohepatitis by fibroblast growth factor 1 in mouse models of nonalcoholic fatty liver disease. | 2016 | Details |
| A18944 | 26856933 | Metabolism | Non-alcoholic fatty liver disease and diabetes. | 2016 | Details |
| A18945 | 26856717 | Dig Dis Sci | Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease. | 2016 | Details |
| A18946 | 26856683 | Clin Obes | Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome. | 2016 | Details |
| A18971 | 26843485 | EMBO J | p38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration. | 2016 | Details |
| A18977 | 26838182 | Food Funct | Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice. | 2016 | Details |
| A18981 | 26834701 | Front Endocrinol (Lausanne) | Fibroblast Growth Factor Signaling in Metabolic Regulation. | 2016 | Details |
| A18985 | 26831892 | BMC Gastroenterol | A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol. | 2016 | Details |
| A18986 | 26831610 | Saudi J Gastroenterol | Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial. | 2017 | Details |
| A18990 | 26830602 | Rev Paul Pediatr | [Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents]. | 2015 | Details |
| A18991 | 26829441 | J Clin Endocrinol Metab | Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease. | 2016 | Details |